Epstein-Barr Virus (EBV) Control

Supplied as a 1 ml liquid aliquot, the Antibodies.com Epstein-Barr Virus (EBV) Control serves as a positive reference reagent for laboratories working on EBV serology, diagnostics, and vaccine-related research. The reagent integrates directly into ELISA and Western blot (WB) workflows as a process control, helping researchers monitor assay reproducibility, lot-to-lot reagent performance, and run-to-run consistency when screening clinical or experimental samples for EBV-specific antibodies.

EBV, a gamma-herpesvirus linked to infectious mononucleosis and to malignancies such as Burkitt lymphoma and nasopharyngeal carcinoma, remains a focal target in immunological and virological research. This control is formulated for in vitro research use and supports laboratories developing or validating immunoassays that distinguish prior EBV exposure, characterize viral capsid antigen (VCA), EBV nuclear antigen (EBNA), or early antigen (EA) reactivity, or quantify anti-EBV antibody titres in seroprevalence studies.

The reagent reduces the need for in-house control generation and supports reproducible benchmarking across multi-site or longitudinal projects. Researchers should store frozen in single-use aliquots to preserve activity and avoid repeated freeze-thaw cycles, handling the material using standard biosafety practices appropriate for a risk group 2 pathogen-derived reagent.